Skip to Content
MilliporeSigma
All Photos(2)

Key Documents

SML3927

Sigma-Aldrich

Alalevonadifloxacin hydrochloride

≥98% (HPLC)

Synonym(s):

L-Alanine 1-[(5S)-2-carboxy-9-fluoro-6,7-dihydro-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizin-8-yl]-4-piperidinyl ester hydrochloride, WCK 2349 hydrochloride

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C22H26FN3O5·HCl
CAS Number:
Molecular Weight:
467.92
UNSPSC Code:
51111800
UNSPSC Code:
12352200
NACRES:
NA.77
Pricing and availability is not currently available.

Quality Level

assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

-10 to -25°C

Biochem/physiol Actions

Orally available L-alanine ester prodrug of Levonadifloxacin that is affective against Gram-positive and Gram-negative bacteria.


Alalevonadifloxacin, the L-alanine ester prodrug of levonadifloxacin, is an orally available and potent benzoquinolizine fluoroquinolone antibiotic that is affective against Gram-positive and Gram-negative bacteria, including methicillin- and quinolone-resistant Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, and Moraxella catarrhalis and atypical pathogens. Alalevonadifloxacin targets staphylococcal DNA gyrase, unlike other quinolones, which primarily inhibit DNA topoisomerase IV.

Caution

Hygroscopic

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence
Drug design, development and therapy, 13, 4351-4365 (2019)
Design and synthesis of an oral prodrug alalevonadifloxacin for the treatment of MRSA infection
Bioorganic & Medicinal Chemistry Letters, 54, 128432-128432 (2021)
Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects
Keith A Rodvold, Mark H Gotfried
Antimicrobial Agents and Chemotherapy, 62(3) (2018)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service